Pertussis antitoxin decay after vaccination with DTPa: Response to a first booster dose 312–612 years after the third vaccine dose
- 16 November 2005
- Vol. 23 (46-47) , 5359-5364
- https://doi.org/10.1016/j.vaccine.2005.06.009
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- European Sero-Epidemiology Network: standardisation of the assay results for pertussisVaccine, 2003
- Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussisVaccine, 2003
- Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccineVaccine, 2003
- Whooping cough---a continuing problemBMJ, 2002
- Antibodies to pertussis antigens in pediatric health care workersThe Pediatric Infectious Disease Journal, 2002
- Recent progress in clinical and basic pertussis research.European Journal of Pediatrics, 2001
- Diphtheria antitoxin response to DTP vaccines used in Swedish pertussis vaccine trials, persistence and projection for timing of boosterVaccine, 2000
- A search for serologic correlates of immunity to Bordetella pertussis cough illnessesVaccine, 1998
- Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussisVaccine, 1998
- A Controlled Trial of a Two-Component Acellular, a Five-Component Acellular, and a Whole-Cell Pertussis VaccineNew England Journal of Medicine, 1996